Multi-Strain Probiotic (UB0316) is effective in reducing BMI, body weight and WHR in overweight/obese adults.

Effect of multi-strain probiotic (UB0316) in weight management in overweight/obese adults: a 12-week double blind, randomised, placebo-controlled study.

M Ratna Sudha, Jayesh Jagannath Ahire, N Jayanthi, Amit Tripathi, S Nanal

Benef Microbes

Dec 9, 2019

Sources

0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

115 views

Abstract

This clinical trial was carried out to assess the effects of multi-strain probiotic capsule (UB0316:UBLS-22,UBLC-42,, UBLP-40,UBLA-34,UBBr-01,Unique IS2 5×10cfu each and fructo-oligosaccharide, 100 mg) on overweight/obesity-related parameters. Ninety subjects (age, 30-65 years; body mass index (BMI), 25-32 kg/m) were randomised into two groups, i.e. UB0316 (probiotic) and placebo (excipient maltodextrin). They were instructed to take 2 capsules (UB0316 or placebo) per day after meals for 12 weeks. Primary (BMI), and secondary (waist-to-hip ratio: WHR; body weight, body fat; sugar and lipid profile) endpoint measures were evaluated at scheduled visits. Vital signs, physical investigations, quality of life, physician/subjects global assessment and adverse events were also recorded. A total of 71 subjects completed the scheduled study visits and analysis thereof showed that a 12-week UB0316 supplementation significantly reduced BMI (95% CI: -0.64, -0.27;=0.0001), body weight (95% CI: -1.16, -0.50;